Sign In
Buy PRCT
$16.69
-0.86 (-4.90%)
At Close: Jul 24, 2026
Procept: Leveraging A Novel Water-Based System For Enlarged Prostate Treatment
01:37am, Thursday, 26'th May 2022
PROCEPT has developed a system to treat enlarged prostate disease, and is banking on competitive advantage over legacy treatment options. The common disease, more prevalent as populations grow older,
PROCEPT BioRobotics Corporation (PRCT) CEO Reza Zadno on Q1 2022 Results - Earnings Call Transcript
03:12am, Sunday, 08'th May 2022
PROCEPT BioRobotics Corporation (NASDAQ:PRCT ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Matt Bacso - Investor Relations Reza Zadno - Chief Executive Officer Kevin W
REDWOOD CITY, Calif., April 12, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative so
Andreas Halvorsen Powers Down Position in PROCEPT BioRobotics
11:54am, Thursday, 24'th Mar 2022
Viking Global leader Andreas Halvorsen (Trades, Portfolio) disclosed earlier this week he curbed his PROCEPT BioRobotics Corp. ( PRCT , Financial) stake by 25.45%.
PROCEPT BioRobotics (PRCT) CEO Reza Zadno on Q4 2021 Results - Earnings Call Transcript
11:37am, Tuesday, 08'th Mar 2022
PROCEPT BioRobotics (PRCT) CEO Reza Zadno on Q4 2021 Results - Earnings Call Transcript
6 Underperforming IPO Stocks To Buy On The Dip
02:47pm, Friday, 04'th Feb 2022
The U.S. IPO market was red-hot in 2021. The total number of traditional U.S. IPOs hit its highest level since the dot-com boom in the late 1990s, while total IPO deal value reached record levels la
PROCEPT BioRobotics' (PRCT) CEO Reza Zadno on Q3 2021 Results - Earnings Call Transcript
08:05am, Sunday, 07'th Nov 2021
PROCEPT BioRobotics' (PRCT) CEO Reza Zadno on Q3 2021 Results - Earnings Call Transcript
PROCEPT BioRobotics Corporation Announces Cigna Adds Aquablation Therapy to its Coverage Policy
07:00am, Tuesday, 28'th Sep 2021
REDWOOD CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative so
REDWOOD CITY, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (“PROCEPT”), a commercial-stage surgical robotics company focused on advancing patient care
U.S. IPO Weekly Recap: The Fall IPO Market Is In Full Swing With An 11 IPO Week
11:50pm, Saturday, 18'th Sep 2021
The IPO market was full steam ahead this past week as 11 IPOs came to market.
Opening Bell, September 16, 2021
02:27pm, Thursday, 16'th Sep 2021
ForgeRock rings the opening bell at the New York Stock Exchange while Procept Biorobotics rings the opening bell at the Nasdaq.
Procept BioRobotics stock debuts with a bang, as stock opens 40% above IPO price
12:12pm, Wednesday, 15'th Sep 2021
Procept BioRobotics Corp. PRCT, +45.96% debuted on Wall Street Wednesday with a bang, as the California-based surgical robotics company's stock opened 40.0% above the up-sized initial public offering'
Procept BioRobotics upsized IPO prices above the expected range, valuing company at $1 billion
06:34am, Wednesday, 15'th Sep 2021
Procept BioRobotics Corp. PRCT, is set to go public Wednesday, as the California-based surgical robotics company's upsized initial public offering priced above the expected range at $25.00 per share.
IPO Previews For The Week
05:37pm, Sunday, 12'th Sep 2021
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are s
